HRIPSIME MANUKYAN: Open Payments
NPI 1841956760 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 38 payments from 12 companies in 2025. Trend: 2023 $625 · 2024 $569 · 2025 $840
Food & beverage: $795Education: $45
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $296 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $106 |
| Pharming Healthcare, Inc. | 3 | $82 |
| Insmed, Inc. | 2 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Baxter Healthcare | 1 | $30 |
| United Therapeutics Corporation | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: TRELEGY ELLIPTA, NUCALA, RUCONEST, OFEV, CUVITRU, DUPIXENT, Hillrom - Vest System Model 105 Home Care, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
